Tumeurs (thérapie) < Tumeurs (traitement médicamenteux) < Tumeurs (virologie)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Tumeurs (traitement médicamenteux)

Number of relevant bibliographic references: 19.

Ident.	Authors (with country if any)	Title
000391 (2019)	Francesca Chiarini [Italie] ; Camilla Evangelisti [Italie] ; Giovanna Lattanzi [Italie] ; James A. Mccubrey [États-Unis] ; Alberto M. Martelli [Italie]	Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells.
000433 (2018)	Laura Hulea [Canada] ; Simon-Pierre Gravel [Canada] ; Masahiro Morita [Japon] ; Marie Cargnello [France] ; Oro Uchenunu [Canada] ; Young Kyuen Im [Canada] ; Camille Lehuédé [Canada] ; Eric H. Ma [Canada] ; Matthew Leibovitch [Canada] ; Shannon Mclaughlan [Canada] ; Marie-José Blouin [Canada] ; Maxime Parisotto [Canada] ; Vasilios Papavasiliou [Canada] ; Cynthia Lavoie [Canada] ; Ola Larsson [Suède] ; Michael Ohh [Canada] ; Tiago Ferreira [Canada] ; Celia Greenwood [Canada] ; Gaëlle Bridon [Canada] ; Daina Avizonis [Canada] ; Gerardo Ferbeyre [Canada] ; Peter Siegel [Canada] ; Russell G. Jones [Canada] ; William Muller [Canada] ; Josie Ursini-Siegel [Canada] ; Julie St-Pierre [Canada] ; Michael Pollak [Canada] ; Ivan Topisirovic [Canada]	Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides.
000440 (2018)	Arash Soltani [Iran] ; Amirhossein Bahreyni [Iran] ; Nadia Boroumand [Iran] ; Mostafa Karimi Roshan [Iran] ; Majid Khazaei [Iran] ; Mikhail Ryzhikov [États-Unis] ; Saman Soleimanpour [Iran] ; Amir Avan [Iran] ; Seyed Mahdi Hassanian [Iran]	Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives.
000617 (2018)	Alberto M. Martelli [Italie] ; Francesca Buontempo [Italie] ; James A. Mccubrey [États-Unis]	Drug discovery targeting the mTOR pathway.
000754 (2017)	James A. Mccubrey [États-Unis] ; Kvin Lertpiriyapong [États-Unis] ; Linda S. Steelman [États-Unis] ; Steve L. Abrams [États-Unis] ; Lucio Cocco [Italie] ; Stefano Ratti [Italie] ; Alberto M. Martelli [Italie] ; Saverio Candido [Italie] ; Massimo Libra [Italie] ; Giuseppe Montalto [Italie] ; Melchiorre Cervello [Italie] ; Agnieszka Gizak [Pologne] ; Dariusz Rakus [Pologne]	Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases.
000918 (2017)	Yuki Kunisada [Japon] ; Shingo Eikawa [Japon] ; Nahoko Tomonobu [Japon] ; Shohei Domae [Japon] ; Takenori Uehara [Japon] ; Shohei Hori [Japon] ; Yukihiro Furusawa [Japon] ; Koji Hase [Japon] ; Akira Sasaki [Japon] ; Heiichiro Udono [Japon]	Attenuation of CD4+CD25+ Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug.
000A44 (2016)	Haiyan Cui [République populaire de Chine] ; Shufen Wu [République populaire de Chine] ; Yunfei Shang [République populaire de Chine] ; Zhenjing Li [République populaire de Chine] ; Mianhua Chen [République populaire de Chine] ; Fengjuan Li [République populaire de Chine] ; Changlu Wang [République populaire de Chine]	Pleurotus nebrodensis polysaccharide(PN50G) evokes A549 cell apoptosis by the ROS/AMPK/PI3K/AKT/mTOR pathway to suppress tumor growth.
000B72 (2015)	Andras Perl [États-Unis]	mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.
000D21 (2015)	Francesca Chiarini [Italie] ; Camilla Evangelisti [Italie] ; James A. Mccubrey [États-Unis] ; Alberto M. Martelli [Italie]	Current treatment strategies for inhibiting mTOR in cancer.
000E42 (2014)	Stephen I. Deutsch [États-Unis] ; Amy H. Tang [États-Unis] ; Jessica A. Burket [États-Unis] ; Andrew D. Benson [États-Unis]	NMDA receptors on the surface of cancer cells: target for chemotherapy?
000E72 (2014)	Ozan Yazici [Turquie] ; Mehmet Ali Nahit Sendur [Turquie] ; Sercan Aksoy [Turquie]	Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.
000F55 (2013)	Xiaoyan Ning [République populaire de Chine] ; Jianchang Shu ; Yiqi Du ; Qiwen Ben ; Zhaoshen Li	Therapeutic strategies targeting cancer stem cells.
001131 (2012)	James A. Mccubrey [États-Unis] ; Linda S. Steelman ; William H. Chappell ; Stephen L. Abrams ; Richard A. Franklin ; Giuseppe Montalto ; Melchiorre Cervello ; Massimo Libra ; Saverio Candido ; Grazia Malaponte ; Maria C. Mazzarino ; Paolo Fagone ; Ferdinando Nicoletti ; Jörg B Secke ; Sanja Mijatovic ; Danijela Maksimovic-Ivanic ; Michele Milella ; Agostino Tafuri ; Francesca Chiarini ; Camilla Evangelisti ; Lucio Cocco ; Alberto M. Martelli	Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.
001153 (2012)	A. Amedei [Italie] ; M M D'Elios	New therapeutic approaches by using microorganism-derived compounds.
001242 (2011)	Lior Ungar [Israël] ; Yaniv Harari ; Amos Toren ; Martin Kupiec	Tor complex 1 controls telomere length by affecting the level of Ku.
001430 (2010)	Sucha Sudarsanam [États-Unis] ; Dale E. Johnson	Functional consequences of mTOR inhibition.
001593 (2008)	Bing-Hua Jiang [États-Unis] ; Ling-Zhi Liu	Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment.
001654 (2008)	Linda S. Steelman [États-Unis] ; Kristin M. Stadelman ; William H. Chappell ; Stefan Horn ; Jörg B Secke ; Melchiorre Cervello ; Ferdinando Nicoletti ; Massimo Libra ; Franca Stivala ; Alberto M. Martelli ; James A. Mccubrey	Akt as a therapeutic target in cancer.
001867 (2004)	Linda S. Steelman [États-Unis] ; Fred E. Bertrand ; James A. Mccubrey	The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Tumeurs (traitement médicamenteux)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Tumeurs (traitement médicamenteux)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Tumeurs (traitement médicamenteux)
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020